Maann Medicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-12-2024
- Paid Up Capital ₹ 0.10 M
as on 21-12-2024
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 Cr
as on 21-12-2024
- Revenue %
(FY 2022)
- Profit 1.75%
(FY 2022)
- Ebitda -204.88%
(FY 2022)
- Net Worth -2.47%
(FY 2022)
- Total Assets 127.68%
(FY 2022)
About Maann Medicals
The Corporate was formerly known as Maan Medex Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.00 Cr.
Jeetendra Belani and Ritika Jeetendra serve as directors at the Company.
- CIN/LLPIN
U74120MH2015PTC270209
- Company No.
270209
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Nov 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Maann Medicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jeetendra Belani  | Director | 17-Nov-2015 | Current |
| Ritika Jeetendra | Director | 10-Jan-2022 | Current |
Financial Performance of Maann Medicals.
Maann Medicals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 1.75% increase in profit. The company's net worth dipped by a decrease of 2.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maann Medicals?
Unlock access to Maann Medicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Castor Lifecare Private LimitedActive 9 years 7 monthsJeetendra Belani and Ritika Jeetendra are mutual person
Jeerima Biocare Private LimitedActive 8 years 4 monthsJeetendra Belani and Ritika Jeetendra are mutual person
- Leehpl Ventures Private LimitedActive 13 years 6 months
Jeetendra Belani and Ritika Jeetendra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Aug 2022 | ₹3.00 Cr | Open |
How Many Employees Work at Maann Medicals?
Unlock and access historical data on people associated with Maann Medicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maann Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maann Medicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
